Elyssa Ott
Impact in
-
- Psoriasis: Treatment and Pathogenesis
-
- Inflammatory Bowel Disease
Papers in
- Genetics 4
- Inflammatory Bowel Disease 4
-
- Psoriasis: Treatment and Pathogenesis 3
- Co-authors
- Michael E. Burczynski (1 shared paper)Subrata K. Ghosh (5 shared papers)Meng Jiao Xu (1 shared paper)Lisa Hickey (1 shared paper)Chandrasekhar Udata (1 shared paper)Arie Katz (1 shared paper)O. Vesterqvist (1 shared paper)Christopher Gasink (5 shared papers)
- Journals
- Gastroenterology (2 papers)Drug Safety (1 paper)Journal of Crohn s and Colitis (1 paper)Inflammatory Bowel Diseases (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Elyssa Ott
10 papers receiving 537 citations
Peers
Comparison fields: 5 of 54
- Immunology 137
- Genetics 146
- Ophthalmology 39
- Rheumatology 41
- Surgery 103
Countries citing papers authored by Elyssa Ott
This map shows the geographic impact of Elyssa Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyssa Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyssa Ott more than expected).
Fields of papers citing papers by Elyssa Ott
This network shows the impact of papers produced by Elyssa Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyssa Ott. The network helps show where Elyssa Ott may publish in the future.
Co-authors
The 25 scholars most cited alongside Elyssa Ott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 170 | |
| 2 | 2019 | 97 | |
| 3 | 2020 | 94 | |
| 4 | An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up. | 2012 | 71 |
| 5 | 2019 | 44 | |
| 6 | 2005 | 42 | |
| 7 | 2024 | 28 | |
| 8 | 2022 | 14 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 1 |
About Elyssa Ott
Elyssa Ott is a scholar working on Genetics, Immunology, Ophthalmology, Public Health, Environmental and Occupational Health and Surgery, having authored 10 papers that have together received 564 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (4 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Cholesterol and Lipid Metabolism (1 paper), Pregnancy and Medication Impact (1 paper) and Glaucoma and retinal disorders (1 paper). The work is most often cited by research in Immunology (137 citations), Genetics (146 citations), Ophthalmology (39 citations), Rheumatology (41 citations) and Surgery (103 citations). Elyssa Ott has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Michael E. Burczynski, Subrata K. Ghosh, Meng Jiao Xu, Lisa Hickey, Chandrasekhar Udata, Arie Katz, O. Vesterqvist, Christopher Gasink, Soumya D. Chakravarty and Lianne S. Gensler. Their work appears in journals such as Gastroenterology, Drug Safety, Journal of Crohn s and Colitis, Inflammatory Bowel Diseases and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.